Dana Kappel

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Dana Kappel is an author at United States Food and Drug Administration specializing in drug labeling for breastfeeding, pregnancy labeling, and drug approval processes.

ORCID

Publications per year

2023–2025

Publications

A Comparison of <scp>FDA</scp> and <scp>EMA</scp> Pregnancy and Lactation Labeling

Dana Kappel, Leyla Şahin, Lynne Yao et al. · Clinical Pharmacology & Therapeutics · 2023 · 24 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +16

FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer

Melanie Royce, Mirat Shah, Joyce Cheng et al. · Clinical Cancer Research · 2025 · 12 citations · Full text

Medicine, Oncology, Pharmacology +16

1–2 of 2